Preferential COX-2 Inhibitor, Meloxicam, Compromises Renal Perfusion in Euvolemic and Hypovolemic Rats

Publisher： Karger

E-ISSN： 1660-2129|8|3|173-180

ISSN： 1660-2129

Source： Nephron Experimental Nephrology, Vol.8, Iss.3, 2000-05, pp. : 173-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Urinary Human L-FABP Is a Potential Biomarker to Predict COX-Inhibitor-Induced Renal Injury

By  

Nephron Experimental Nephrology, Vol. 108, Iss. 1, 2008-01 ,pp. : e19-e26

Karger

Access to resources Recommend Favorite

Cyclooxygenase-2 Inhibitor Decreases Extracellular Matrix Synthesis in Stretched Renal Fibroblasts

By  

Nephron Experimental Nephrology, Vol. 100, Iss. 4, 2005-04 ,pp. : e150-e155

Karger

Access to resources Recommend Favorite

Renal Effects of Nabumetone, a COX-2 Antagonist: Impairment of Function in Isolated Perfused Rat Kidneys Contrasts with Preserved Renal Function in vivo

By  

Nephron Experimental Nephrology, Vol. 9, Iss. 6, 2001-11 ,pp. : 387-396

Karger

Access to resources Recommend Favorite

Beneficial Effect of the Long-Term Treatment with the Combination of an ACE Inhibitor and a Calcium Channel Blocker on Renal Injury in Rats with 5/6 Nephrectomy

By  

Nephron Experimental Nephrology, Vol. 6, Iss. 1, 1998-02 ,pp. : 39-49

Karger

Access to resources Recommend Favorite

Renal ACE and ACE2 Expression in Early Diabetic Rats

By  

Nephron Experimental Nephrology, Vol. 110, Iss. 1, 2008-08 ,pp. : e8-e16

Karger

Access to resources Recommend Favorite